← Back to Search
Improving Motor Skill Development in Infants After Cardiac Surgery (DAISY Trial)
Ann Arbor, MI
N/A
Waitlist Available
Led By Karen Uzark, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after hospital discharge
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this study is to learn more about developmental behaviors and to examine changes in developmental progress related to motor activities among a group of infants who received open heart surgery within the first three months of life.
See full description
Eligible Conditions
- Congenital Heart Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months after hospital discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after hospital discharge
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Gross Motor Scale score
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: inpatient/outpatientExperimental Treatment2 Interventions
Inpatient and outpatient recommendations to parents regarding infant motor activities
Group II: inpatientExperimental Treatment2 Interventions
Inpatient recommendations to parents regarding infant motor activities
Group III: standard careActive Control1 Intervention
Standard care comparison
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard care
2007
Completed Phase 4
~9600
Developmental recommendations
2016
N/A
~70
Find a Location
Closest Location:University of Michigan· Ann Arbor, MI· 165 miles
Who is running the clinical trial?
University of MichiganLead Sponsor
1,887 Previous Clinical Trials
6,462,298 Total Patients Enrolled
Karen Uzark, PhDPrincipal InvestigatorUniversity of Michigan